A trial of vemurafenib for children with advanced melanoma (BRIM-P)

This trial looked at a drug called vemurafenib for children and teenagers with advanced melanoma. It was for children and young people aged 12 to 17 whose melanoma:

• had grown into surrounding tissues and couldn’t be removed with surgery or

• had spread to another part of the body

The trial was open for people to join between 2011 and 2015. The team published the results in 2018. There is a link to more information in the ‘Summary of results’ section below.